Ramtin Agah - 30 Dec 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Issuer symbol
RNXT
Transactions as of
30 Dec 2025
Net transactions value
+$169
Form type
4
Filing time
02 Jan 2026, 17:00:20 UTC
Previous filing
17 Dec 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Agah Ramtin Chief Medical Officer, Director C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW /s/ Ramtin Agah 02 Jan 2026 0001862617

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase $169 +205 +0.03% $0.8260 778,665 30 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases of the Issuer's securities.
F2 Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.825 to $0.873.